Stella Diagnostics, Inc. (SLDX)

Market Cap	19.68M
Revenue (ttm)	n/a
Net Income (ttm)	-257.97K
Shares Out	401.60M
EPS (ttm)	-7.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	1,593
Open	0.0490
Previous Close	0.0400
Day's Range	0.0490 - 0.0490
52-Week Range	0.0400 - 0.0900
Beta	-7.63
RSI	49.12
Earnings Date	n/a

About Stella Diagnostics

Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology notifies gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: David Seaburg
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: SLDX